genedrive plc (AIM:GDR)
London · Delayed Price · Currency is GBP · Price in GBX 1.250
0.00 (0.00%)
Sep 18, 2026, 4:35 PM GMT
genedrive Market Cap
genedrive has a market cap or net worth of 20.07 million as of September 18, 2026. Its market cap has increased by 458.55% in one year.
Market Cap
20.07M
Enterprise Value
20.18M
Revenue
1.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.25
ChartMarket Cap Chart
Since April 10, 2007, genedrive's market cap has increased from 11.67M to 20.07M, an increase of 71.97%. That is a compound annual growth rate of 2.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 20.07M | 122.77% |
| Dec 31, 2025 | 9.01M | -32.30% |
| Dec 31, 2024 | 13.31M | 33.76% |
| Dec 29, 2023 | 9.95M | -2.27% |
| Dec 30, 2022 | 10.18M | -74.34% |
| Dec 31, 2021 | 39.68M | 29.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 192.76B |
| GSK plc | 76.13B |
| Haleon | 29.92B |
| Smith & Nephew | 8.71B |
| Provexis | 25.45M |
| ImmuPharma | 24.83M |
| SkinBioTherapeutics | 22.68M |
| RUA Life Sciences | 17.69M |